BPD-Mingrone: Effect of Biliopancreatic Diversion on Glucose Homeostasis
Study Details
Study Description
Brief Summary
Biliopancreatic diversion (BPD) surgery results in greater resolution of type 2 diabetes than all other bariatric surgical procedures, and it is hypothesized that this procedure has specific beneficial effects on glucose homeostasis beyond weight loss alone. The BPD procedure is performed in more than 150 patients/year by surgeons at the Division of Obesity and Metabolic Disorders, Catholic University of the Sacred Heart, School of Medicine, in Rome, Italy. The purpose of this study is to provide a better understanding of the effect of the BPD bariatric surgical procedure on insulin action and pancreatic beta cell function. It is hypothesized that weight loss achieved with BPD surgery will have greater effects on insulin sensitivity and beta cell function than weight loss induced by Roux-en-Y gastric bypass (RYGB).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: RYGB Subjects received Roux-en-Y Gastric Bypass surgery. |
Procedure: Roux-en-Y Gastric Bypass Surgery
In Roux-en-Y Gastric Bypass Surgery a small gastric pouch is created and connected to a segment of jejunum. Bowel continuity is restored by reconnecting the "Roux" limb and the biliopancreatic limb approximately ~75-150 cm distal to the gastrojejunostomy. Therefore, ingested food bypasses most of the stomach, the entire duodenum, and a short segment of the jejunum.
|
Experimental: BPD Subjects received Biliopancreatic Diversion Surgery |
Procedure: Biliopancreatic Diversion Surgery
In Biliopancreatic Diversion Surgery a horizontal gastrectomy is conducted leaving a portion of the stomach, which is connected to the small intestine, ~250 cm from the ileocecal valve and the biliopancreatic limb is connected to the ileum, ~50 cm from the ileocecal valve. Digestive secretions from the biliopancreatic limb mix in the common channel, where ingested food is also delivered by the alimentary limb.
|
Outcome Measures
Primary Outcome Measures
- Change from baseline in skeletal muscle insulin sensitivity will be assessed using the Hyperinsulinemic-Euglycemic Clamp (HEC) procedure, before and after weight loss induced by either BPD or RYGB surgery [Change from Baseline up to a possible 9 months]
Insulin sensitivity: The HEC procedure will be used to evaluate insulin sensitivity before and after 20% weight loss induced by either BPD or RYGB surgery
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Body Mass Index (BMI) ≥ 35 kg/m²
-
Undergoing either the RYGB or the BPD procedure.
-
Able to provide informed consent to participate in the research study
Exclusion Criteria:
-
Weight > 450 pounds
-
Smoke > 7 cigarettes per day
-
Previous malabsorptive or restrictive intestinal surgery
-
Pregnant or breastfeeding
-
Inflammatory intestinal disease
-
Diabetes
-
Unstable dose of medications in the last 4 weeks before the pre-surgery metabolic studies
-
Severe organ dysfunction
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Catholic University of the Sacred Heart | Rome | Italy | 00128 |
Sponsors and Collaborators
- Washington University School of Medicine
- Catholic University of the Sacred Heart
- The Foundation for Barnes-Jewish Hospital
Investigators
- Principal Investigator: Samuel Klein, MD, Washington University School of Medicine
- Principal Investigator: Geltrude Mingrone, MD, PhD, Catholic University of the Sacred Heart
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 411/14